Fineline Cube

Follow:
14475 Articles
Company

Huadong Medicine Reports 10.4% Revenue Growth in Q3 2022

CompanyDrug

CSPC Receives CDE Approval for Generic Version of Pfizer’s Xeljanz

CompanyDeals

Giant Biogene Set for IPO on Hong Kong Stock Exchange to Raise Funds for Expansion

CompanyDeals

BIMI International Medical to Sell Off Underperforming Subsidiary Chongqing Zhuoda

CompanyDeals

Shandong Branden Medical Devices Files for IPO on STAR Board to Raise RMB 760M

CompanyDeals

Gan & Lee Pharmaceuticals Plans RMB 814M Private Placement for Working Capital

CompanyDeals

Rongsheng Bio Set for IPO on STAR Board to Boost Vaccine R&D

CompanyDrug

Daiichi Sankyo Initiates Global Phase II Study of DS7300 for Small-Cell Lung Cancer

CompanyDrug

Abbisko’s ABSK021 Gets CDE Approval for Phase III Study in Giant Cell Tumor of Tendon Sheath

CompanyDrug

Livzon Launches National Rollout of COVID-19 Vaccine V-01 in China

CompanyDeals

Venmedtech Raises Series B+ Funding for Iliac Vein Stent and Product R&D

CompanyDeals

Celgenyx Completes RMB 100M Series A Financing for Next-Gen Cell Therapy Development